TAF has a higher risk of hypertension than TDF, according to an HIV pre-exposure prophylaxis study.

Published Date: 20 Sep 2023

Tenofovir alafenamide fumarate (TAF) use was linked to more instances of hypertension in patients receiving pre-exposure prophylaxis (PrEP), according to research from Kaiser Permanente Southern California, Pasadena.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

2.

Do Anatomy Atlases Reflect Social Inequalities?

3.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

4.

Some triple negative breast cancers might be avoided by longer breastfeeding

5.

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot